Bank Of The West Gilead Sciences, Inc. Transaction History

Bank Of The West

$851 Million
Q4 2022

A detailed history of Bank Of The West transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bank Of The West holds 75,700 shares of GILD stock, worth $6.69 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

75,700

Previous 60,033 26.1%

Holding current value

$6.69 Million

Previous $3.7 Million 75.43%

% of portfolio

0.76%

Previous 0.48%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$62.32 - $89.47 $976,367 - $1.4 Million	15,667 Added 26.1%	75,700 $6.5 Million
Q3 2022 Oct 31, 2022	BUY	$59.54 - $68.01 $242,387 - $276,868	4,071 Added 7.27%	60,033 $3.7 Million
Q2 2022 Aug 02, 2022	BUY	$57.72 - $65.01 $39,076 - $44,011	677 Added 1.22%	55,962 $3.46 Million
Q1 2022 Apr 22, 2022	BUY	$57.92 - $72.58 $207,469 - $259,981	3,582 Added 6.93%	55,285 $3.29 Million
Q4 2021 Jan 28, 2022	BUY	$64.88 - $73.64 $48,140 - $54,640	742 Added 1.46%	51,703 $3.75 Million
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $373,107 - $402,541	5,512 Added 12.13%	50,961 $3.56 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $67,722 - $73,996	1,067 Added 2.4%	45,449 $3.13 Million
Q1 2021 May 10, 2021	SELL	$60.0 - $68.46 $1.22 Million - $1.4 Million	-20,390 Reduced 31.48%	44,382 $2.87 Million
Q4 2020 Feb 02, 2021	BUY	$56.65 - $64.55 $195,839 - $223,149	3,457 Added 5.64%	64,772 $3.77 Million
Q3 2020 Nov 05, 2020	SELL	$62.1 - $78.08 $536,233 - $674,220	-8,635 Reduced 12.34%	61,315 $3.87 Million
Q2 2020 Aug 10, 2020	BUY	$72.34 - $84.0 $691,208 - $802,620	9,555 Added 15.82%	69,950 $5.38 Million
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $1.2 Million - $1.53 Million	-19,111 Reduced 24.04%	60,395 $4.52 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $126,197 - $138,813	-2,048 Reduced 2.51%	79,506 $5.17 Million
Q3 2019 Oct 28, 2019	BUY	$62.51 - $69.0 $110,892 - $122,406	1,774 Added 2.22%	81,554 $5.17 Million
Q2 2019 Jul 18, 2019	BUY	$61.87 - $69.38 $127,761 - $143,269	2,065 Added 2.66%	79,780 $5.39 Million
Q1 2019 Apr 09, 2019	BUY	$62.53 - $70.05 $442,462 - $495,673	7,076 Added 10.02%	77,715 $5.05 Million
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $313,718 - $409,378	-5,182 Reduced 6.83%	70,639 $4.42 Million
Q3 2018 Nov 02, 2018	SELL	$71.28 - $78.92 $79,049 - $87,522	-1,109 Reduced 1.44%	75,821 $5.85 Million
Q2 2018 Jul 25, 2018	BUY	$64.88 - $75.68 $61,506 - $71,744	948 Added 1.25%	76,930 $5.45 Million
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $626,351 - $763,591	-8,599 Reduced 10.17%	75,982 $5.73 Million
Q4 2017 Feb 05, 2018	SELL	$71.15 - $83.52 $122,306 - $143,570	-1,719 Reduced 1.99%	84,581 $6.06 Million
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $6.22 Million - $7.38 Million	86,300	86,300 $6.99 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of The West, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of The West with notifications on news.

Account